[422 Pages Report] The global vascular endothelial growth factor inhibitors market is expected to be worth US$ 22.7 billion by the end of 2022, and to grow at a CAGR of 4.0% to be worth US$ 33.5 billion by 2032. According to a recent study by Future Market Insights, biologics are leading the market as drugs, with …
Category Archives: Healthcare Trends
Mammography Market is anticipated to grow at around 6.5% to 9% CAGR between 2022 and 2032
In 2022, the global Mammography Market is expected to be worth approximately US$ 1.7 billion. However, with the alarming rise in the prevalence of breast cancer, the overall demand for mammography systems is expected to grow at a 6.5% to 9% CAGR between 2022 and 2032, totalling more than US$ 3.4 billion by 2032. Mammography …
Biomedical Refrigerators and Freezers Market is projected to record a CAGR of 5.9% from 2022 to 2032
The biomedical refrigerators and freezers market is projected to record a CAGR of 5.9% during the forecast period, up from US$ 3.2 Bn in 2020 to reach a valuation of US$ 6 Bn by 2031 Biomedical refrigerators and freezers are medical equipment, used for storing various biological samples such as biological reagents, blood, blood derivatives, medicines, vaccines, deoxyribonucleic …
Optical Imaging Market is expected to register a CAGR of 10.8% from 2022 to 2032 | FMI Study
The global optical imaging market stood at US$ 2.33 Billion in the year 2022 and is expected to reach US$ 6.5 Billion by the year 2032 at a CAGR of 10.8% between 2022 and 2032. With rising preference for non-invasive technology along with increasing incidences of ocular disorders and chronic diseases, the optical imaging market is expected …
Digital Therapeutics Market is expected to reach US$ 42.5 Billion by the end of 2032, with sales revenue expected to register a 24.4% CAGR
[300 Pages Report] As per Future Market Insights, the global digital therapeutics market is forecast to reach US$ 4.8 Bn in 2022, with sales growing at an impressive 24.4% CAGR over the forecast period. The market size will reach US$ 42.5 Bn by 2032. To infiltrate and disrupt the healthcare sector, IT companies are producing and acquiring digital …
Microbial Identification Market is expected to reach US$ 10.7 billion by 2032 at a CAGR of 11.3 %
The global Microbial Identification Market is anticipated to reach a value of US$ 3.7 billion in 2022 and to grow at a CAGR of 11.3% from 2022 to 2032, reaching a value of about US$ 10.7 billion by 2032. One of the main factors propelling the microbial identification market is the rising demand for microbial …
Vascular Closure Devices Market is projected to reach US$ 2.4 Billion by 2032 at a CAGR of 5.4%
The global Vascular Closure Device Market is expected to grow with an opulent CAGR of 5.4% during the forecast period from 2022 to 2032. The global market reached US$ 1.3 Bn in 2021 and is expected to enjoy a valuation of US$ 1.4 Bn by the end of 2022. The surge in usage of vascular closure …
Demand in Europe for Pharmaceutical Filtration Market is projected to register a CAGR of 7.9% from 2022 to 2032
With a remarkable CAGR of 8.7% from 2022 to 2032, the worldwide Pharmaceutical Filter Market was predicted to generate abundant potential prospects. By the end of 2022, the global market is projected to be worth US$ 17.8 billion, and by the end of 2032, it will be worth US$ 41.0 billion. A new analysis indicates …
Allergy Diagnostics Market is likely to reach US$ 11.8 Billion by 2033 at a CAGR of 7.7 %
The global Allergy Diagnostics Market is anticipated to expand at a 7.7% CAGR from 2023 to 2033, according to FMI. The markets for allergy diagnostics are now led by the United States and Canada. Food and medication allergies, the availability of developed infrastructure, and increased consumer healthcare spending all contributed to consistent growth throughout the …
Biopharmaceutical Contract Manufacturing Market is projected to reach US$ 18.65 Billion by 2029 at a 10.5% CAGR
Global Biopharmaceutical Contract Manufacturing Market was estimated to be worth roughly US$ 9.3 Billion in 2022 and is expected to grow at a CAGR of 10.5% to reach US$ 18.7 billion by 2029. A few benefits provided by biopharmaceutical manufacturing businesses include access to pricey technologies, a shorter overall time to market investment for new pharmaceuticals, …